Ascentage Pharma Group International
AAPG | NASDAQ
$16.02
+$0.16 (+1.01%)
Sep 22, 2026, 10:58 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.45B | -1.82B | -1.75B | -405.43M | -360.28M | -932.86M | -853.16M | -864.1M | -836.64M | -832.25M | -753.85M |
Depreciation & Amortization | 84.78M | 47.94M | 51.89M | 93.17M | 94.93M | 93.2M | 50.14M | 35.61M | 33.24M | 16.72M | 27.71M |
Stock-Based Compensation | n/a | 26.1M | 38.29M | 20.92M | 21.98M | 31.5M | 34.78M | 27.58M | 31.08M | 43.52M | 60.5M |
Other Working Capital | n/a | n/a | 15.04M | 15.04M | 29.24M | 112.22M | 125.79M | 85.62M | 166.59M | 247.55M | 68.52M |
Other Non-Cash Items | -17.38M | 521.28M | 1.34B | 31M | -438.98M | 14.38M | -121.49M | -5.96M | 42.14M | 4.02M | -47.13M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | 87.36M | 87.36M | -69.01M | -9.15M | 112.07M | 104.41M | 147.03M | 189.65M | 39.58M |
Operating Cash Flow | -1.38B | -1.23B | -235.25M | -172.98M | -751.36M | -802.93M | -777.66M | -702.46M | -583.15M | -578.35M | -673.2M |
Capital Expenditures | -19.48M | -27.79M | -27.8M | -24.29M | -28.66M | -56.84M | -163.19M | -236.96M | -336.8M | -436.63M | -344.05M |
Cash Acquisitions | -763.46K | -43.56M | -52.32M | -9.52M | -20M | -18.51M | -8.51M | -20M | -28.1M | -36.2M | -18.1M |
Purchase of Investments | -296.97M | -927.12M | -662.94M | -145.38M | -84.9M | -687.1K | -96.35M | -130M | -956.91M | -1.78B | -1.98B |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 96.65M | 96.65M | n/a | n/a | 894.89M | 1.79B | 2.05B |
Other Investing Acitivies | 934.86M | -21.99 | -218.04M | -218.16M | -8.08M | 422.69K | -41.72M | -20.9M | 788.82M | -11.61M | -629.75M |
Investing Cash Flow | 617.65M | -998.21M | -931.02M | -367.53M | -44.99M | 30.28M | -283.69M | -374.19M | 379.36M | -477.25M | -915.48M |
Debt Repayment | 373.57M | 312.31M | 5.21M | -143.32M | 16.97M | 102.46M | 334.58M | 695.87M | 622.23M | 548.59M | 490.7M |
Common Stock Repurchased | -7.74M | -9.2M | -7.22M | 23.55K | -7.88M | -5.92M | -13.39M | -26.78M | -26.33M | -25.87M | -12.94M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -11.75M | -21.39M | -27.92M | 520.19M | 354.48M | -113.96M | -106.24M | -23.24M | -50.95M | -26.72M | 465.92M |
Financial Cash Flow | 1.7B | 2.57B | 911.3M | 379.71M | 363.57M | 452.66M | 685.03M | 645.86M | 1.2B | 1.8B | 1.91B |
Net Cash Flow | 310.1M | 341.24M | 572.77M | -175.91M | -469.36M | -323.36M | -203.56M | -722.49M | 293.83M | 1.34B | 1.31B |
Free Cash Flow | -1.4B | -1.24B | -216.89M | -135.64M | -740.66M | -782.92M | -858.61M | -890.88M | -966.09M | -1.04B | -951.37M |
Adj. Free Cash Flow | -1.4B | -1.27B | -255.18M | -156.57M | -762.65M | -814.42M | -893.39M | -918.46M | -997.18M | -1.08B | -1.01B |
Maintenance CapEx | -31.77M | -20.04M | -32.17M | -12.13M | -12.13M | -12.13M | -44.85M | -129.09M | -254.83M | -380.57M | -365.84M |
Growth CapEx | -15.51M | -32.04M | -24.29M | -69M | -179.72M | -281.68M | -455.14M | -544.5M | -426.02M | -307.54M | -144.66M |
Owner Earnings | -1.6B | -1.34B | -933.26M | -849.57M | -1.42B | -1.39B | -1.37B | -1.39B | -1.49B | -1.6B | -1.51B |
Add to Watchlist
Select watchlists to add or remove AAPG